$1–2 Per Month Could Help Solve Access To Essential Medicines Problem, Experts Say
Just $13 a year could provide a basic set of affordable medicines to all people in low- and middle-income countries, experts commissioned by The Lancet say in a report calling for better access to essential medicines. But views differ as to whether all the recommendations in the report are appropriate or go far enough to address the roots of the problem.
You may also be interested in...
The report by the independent panel shows that the companies that develop and produce medicines, and the non-governmental organizations working on health issues at local level, still disagree fundamentally on the best way to go about improving access to those medicines. While R&D firms are skeptical of the report’s recommendations, the feeling among NGOs seems to be that this report represents something of a landmark development in the access debate.
The UK medicines regulator has a “unique opportunity” to evaluate the systems it operates and to “do things differently", according to its long-term interim head, June Raine.
The pharmaceutical industry has given a muted welcome to proposals for building up the EU's resilience to medicine shortages, saying many of the ideas will not tackle the root causes of supply problems and could even serve to undermine innovation.